Sunday, 15 May 2011


Myteka (Montelukast Sodium)

Myteka (montelukast sodium), a leukotriene receptor antagonist, acts selectively, specifically inhibiting the cysteinyl leukotriene receptor. It is orally active.

Prophylaxis and treatment of chronic Asthma.
Prevention of day and night asthma symptoms.
Treatment of Aspirin sensitive asthmatic patients.
Prevention of exercise induced bronchoconstriction.
Day and night time symptoms of seasonal and perennial allergic rhinitis.

Use During Pregnancy
Since montelukast has not been studied in pregnant women, Myteka tablets and sachets should be used cautiously and only when the benefits outweigh the risks.

No comments:

Post a Comment